Storyline
From the beginning to today
Anthropic has opened a research biolaboratory in the San Francisco Bay Area to accelerate drug development using artificial intelligence. This marks the company's transition from computer modeling to real biological experiments aimed at addressing rare and complex diseases.
1 of 1 events
the editorial blocs represented in the collected reporting
5 of 7 blocs are not represented in the collected reporting.